(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  37  38  39  40  41  42  43  44  45  46  Next »
Emerging Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

Contains 197 pages and 6 tables



 

$3080.00
       
Japan Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country

This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$3000.00
       
2021-2025 France Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report fromVPGMarketResearch.com provides France sales and market share estimates for major suppliers of molecular diagnostic products....

 

$3000.00
       
2021-2025 Germany Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report from VPGMarketResearch.com provides Germany sales and market share estimates for major suppliers of molecular diagnostic products....

 

$3000.00
       
2021-2025 Italy Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report from VPGMarketResearch.com provides Italy sales and market share estimates for major suppliers of molecular diagnostic products....

 

$3000.00
       
2021-2025 Japan Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report from VPGMarketResearch.com provides Japan sales and market share estimates for major suppliers of molecular diagnostic products....

 

$3000.00
       
2021-2025 Spain Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report from VPGMarketResearch.com provides Spain sales and market share estimates for major suppliers of molecular diagnostic products....

 

$3000.00
       
2021-2025 UK Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers

This unique report from VPGMarketResearch.com provides UK sales and market share estimates for major suppliers of molecular diagnostic products....

 

$3000.00
       
Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)

The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing....

 

$2995.00
       
US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test

This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$2950.00
       
Germany Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country

This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$2950.00
       
Spain Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country

This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$2950.00
       
World Cell Surface Markers Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies....


 

$2900.00
       
POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers

This new 305-page report from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.

 

$2900.00
       
2023 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

This new report from Venture Planning Group provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

 

$2900.00
       
2023 US POC Lipid Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers

This new report from Venture Planning Group provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.

 

$2900.00
       
Future Horizons and Growth Strategies in the US Point-of-Care/POC Lipid Testing Market 2019: Supplier Shares and Country Forecasts

This new 305-page report from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.

 

$2900.00
       
Future Horizons and Growth Strategies in the US PT and APTT Point-of-Care/POC Testing Market 2014: Supplier Shares and Country Forecasts

This new 337-page report from Venture Planning Group contains 31 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

 

$2900.00
       
« Previous     37  38  39  40  41  42  43  44  45  46   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X